Lonza CEO Pierre-Alain Ruffieux to Leave
Lonza CEO Pierre-Alain Ruffieux to Leave
Read moreTag: Pharmaceuticals
The Brash Strategy That Made Vivek Ramaswamy a Fortune
Updated Sept. 9, 2023 10:51 am ETVivek Ramaswamy was a novice biotech entrepreneur in 2016 with ...
Read more
J&J Dividend Decision Shows Power of Free Cash Flow
Text size Johnson & Johnson Benadryl brand allergy medication is now a part of Kenvue. Daniel ...
Read more
Rite Aid Prepares Bankruptcy That Would Halt Opioid Lawsuits
Resume Subscription We are delighted that you'd like to resume your subscription. You will be charged ...
Read more
J&J’s Kenvue Deal Could Be Too Popular. What Happens if It Is.
Text size Johnson & Johnson took the Kenvue consumer-health business public in May. Mark Ralston/Getty Images ...
Read more
JNJ Kenvue Exchange Offer Is Almost Here. What to Do Now.
Text size The Johnson & Johnson campus in Irvine, California. Mario Tama/Getty Images It’s crunchtime for ...
Read more
Want to Make $1,000 in 2 Weeks? Buy 99 Shares of J&J Stock.
Many individual investors are trying to do that by purchasing 99 shares of Johnson & Johnson ...
Read more
Eli Lilly Stock Jumps After Strong Earnings and Sales. Obesity Drugs Delivered.
Text size Analysts project that Mounjaro will be the best-selling drug of all time. Dreamstime Sales ...
Read more
J&J’s $40 Billion Kenvue Stock Swap: What You Need to Know
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to ...
Read more
Johnson & Johnson Rips Off the Kenvue Band-Aid
Johnson & Johnson Rips Off the Kenvue Band-Aid
Read more